Epidemiological, clinical and genetic study of familial amyloidotic polyneuropathy in Cyprus

References

• Hou X, Aguilar M I, Small D H. Transthyretin and familial amyloidotic polyneuropathy. Recent progress in understanding the molecular mechanism of neurodegeneration. FEBS J 2007; 274: 1637–1650
   PubMed Web of Science ®Google Scholar
• Plante-Bordeneuve V, Said G. Transthyretin related familial amyloid polyneuropathy. Curr Opin Neurol 2000; 13: 569–573
   PubMed Web of Science ®Google Scholar
• Andrade C. A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain 1952; 75: 408–427
   PubMed Web of Science ®Google Scholar
• Andersson R. Familial amyloidosis with polyneuropathy. A clinical study based on patients living in northern Sweden. Acta Med Scand Suppl 1976; 590: 1–64
   PubMedGoogle Scholar
• Sakoda S, Suzuki T, Higa S, Ueji M, Kishimoto S, Hayashi A, Yasuda N, Takaba Y, Nakajima A. Genetic studies of familial amyloid polyneuropathy in the Arao district of Japan: I. The genealogical survey. Clin Gen 1983; 24: 334–338
   Google Scholar
• Bittencourt P L, Couto C A, Clemente C, Farias A Q, Palacios S A, Mies S, Goldberg A C. Phenotypic expression of familial amyloid polyneuropathy in Brazil. Eur J Neurol 2005; 12: 289–293
   PubMed Web of Science ®Google Scholar
• Munar-Ques M, Saraiva M J, Viader-Farre C, Zabay-Becerril J M, Mulet-Ferrer J. Genetic epidemiology of familial amyloid polyneuropathy in the Balearic Islands (Spain). Amyloid: J Protein Fold Dis 2005; 12: 54–61
   PubMed Web of Science ®Google Scholar
• Coelho T. Familial amyloid polyneuropathy: new developments in genetics and treatment. Curr Opin Neurol 1996; 9: 355–359
   PubMed Web of Science ®Google Scholar
• Misu K, Hattori N, Nagamatsu M, Ikeda S, Ando Y, Nakazato M, Takei Y, Hanyu N, Usui Y, Tanaka F, Harada T, Inukai A, Hashizume Y, Sobue G. Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan. Clinicopathological and genetic features. Brain 1999; 122(Pt 10)1951–1962
   PubMedGoogle Scholar
• Tashima K, Ando Y, Ando E, Tanaka Y, Ando M, Uchino M. Heterogeneity of clinical symptoms in patients with familial amyloidotic polyneuropathy (FAP TTR Met30). Amyloid: The Int J Exp Clin Invest 1997; 4: 108–111
   Google Scholar
• Sousa A, Andersson R, Drugge U, Holmgren G, Sandgren O. Familial amyloidotic polyneuropathy in Sweden: geographical distribution, age of onset, and prevalence. Hum Hered 1993; 43: 288–294
   PubMed Web of Science ®Google Scholar
• Sousa A, Coelho T, Barros J, Sequeiros J. Genetic epidemiology of familial amyloidotic polyneuropathy (FAP)-type I in Povoa do Varzim and Vila do Conde (north of Portugal). Am J Med Genet 1995; 60: 512–521
   PubMed Web of Science ®Google Scholar
• Holt I J, Harding A E, Middleton L, Chrysostomou G, Said G, King R H, Thomas P K. Molecular genetics of amyloid neuropathy in Europe. Lancet 1989; 1: 524–526
   PubMed Web of Science ®Google Scholar
• Holmgren G, Costa P M, Andersson C, Asplund K, Steen L, Beckman L, Nylander P O, Teixeira A, Saraiva M J, Costa P P. Geographical distribution of TTR met30 carriers in northern Sweden: discrepancy between carrier frequency and prevalence rate. J Med Gen 1994; 31: 351–354
   PubMed Web of Science ®Google Scholar
• Drugge U, Andersson R, Chizari F, Danielsson M, Holmgren G, Sandgren O, Sousa A. Familial amyloidotic polyneuropathy in Sweden: a pedigree analysis. J Med Genet 1993; 30: 388–392
   PubMed Web of Science ®Google Scholar
• Yoshioka K, Furuya H, Sasaki H, Saraiva M J, Costa P P, Sakaki Y. Haplotype analysis of familial amyloidotic polyneuropathy. Evidence for multiple origins of the Val–Met mutation most common to the disease. Hum Genet 1989; 82: 9–13
   PubMed Web of Science ®Google Scholar
• Ohmori H, Ando Y, Makita Y, Onouchi Y, Nakajima T, Saraiva M J, Terazaki H, Suhr O, Sobue G, Nakamura M, Yamaizumi M, Munar-Ques M, Inoue I, Uchino M, Hata A. Common origin of the Val30Met mutation responsible for the amyloidogenic transthyretin type of familial amyloidotic polyneuropathy. J Med Genet 2004; 41: e51
   PubMed Web of Science ®Google Scholar
• Ikeda S, Nakazato M, Ando Y, Sobue G. Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity. Neurology 2002; 58: 1001–1007
   PubMed Web of Science ®Google Scholar
• Conceicao I, De Carvalho M. Clinical variability in type I familial amyloid polyneuropathy (Val30Met): comparison between late- and early-onset cases in Portugal. Muscle Nerve 2007; 35: 116–118
   PubMed Web of Science ®Google Scholar
• Araki S, Mawatari S, Ohta M, Nakajima A, Kuroiwa Y. Polyneuritic amyloidosis in a Japanese family. Arch Neurol 1968; 18: 593–602
   PubMed Web of Science ®Google Scholar
• Kito S, Itoga E, Kamiya K, Kishida T, Yamamura Y. Studies on familial amyloid polyneuropathy in Ogawa Village, Japan. Eur Neurol 1980; 19: 141–151
   PubMed Web of Science ®Google Scholar
• Reilly M M, Adams D, Davis M B, Said G, Harding A E. Haplotype analysis of French, British and other European patients with familial amyloid polyneuropathy (met 30 and tyr 77). J Neurol 1995; 242: 664–668
   Google Scholar
• Almeida M R, Aoyama-Oishi N, Sakaki Y, Holmgren G, Ulf D, Ferlini A, Salvi F, Munar-Oues M, Benson M D, Skinner M, Costa P P, Saraiva M J. Haplotype analysis of common transthyretin mutations. Hum Genet 1995; 96: 350–354
   PubMedGoogle Scholar
• Koike H, Misu U, Ikeda S, Ando Y, Nakazato M, Ando E, Yamamoto M, Hattori N, Sobue G. Type I (transthyretin Met30) familial amyloid polyneuropathy in Japan: early- vs. late-onset form. Arch Neurol 2002; 59: 1771–1776
   PubMed Web of Science ®Google Scholar
• Misu K, Hattori N, Ando Y, Ikeda S, Sobue G. Anticipation in early- but not late-onset familial amyloid polyneuropathy (TTR met 30) in Japan. Neurology 2000; 55: 451–452
   PubMed Web of Science ®Google Scholar
• Soares M, Buxbaum J, Sirugo G, Coelho T, Sousa A, Kastner D, Saraiva M J. Genetic anticipation in Portuguese kindreds with familial amyloidotic polyneuropathy is unlikely to be caused by triplet repeat expansions. Hum Genet 1999; 104: 480–485
   PubMed Web of Science ®Google Scholar
• Yamamoto K, Ikeda S, Hanyu N, Takeda S, Yanagisawa N. A pedigree analysis with minimised ascertainment bias shows anticipation in Met30-transthyretin related familial amyloid polyneuropathy. J Med Genet 1998; 35: 23–30
   PubMed Web of Science ®Google Scholar
• Soares M L, Coelho T, Sousa A, Batalov S, Conceicao I, Sales-Luis M L, Ritchie M D, Williams S M, Nievergelt C M, Schork N J, Saraiva M J, Buxbaum J N. Susceptibility and modifier genes in Portuguese transthyretin V30M amyloid polyneuropathy: complexity in a single-gene disease. Hum Mol Genet 2005; 14: 543–553
   PubMed Web of Science ®Google Scholar
• Croce C M. Oncogenes and cancer. N Engl J Med 2008; 358: 502–511
   PubMed Web of Science ®Google Scholar